Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 |
filingDate |
2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2017530129-A |
titleOfInvention |
Method for treating cancer using tubulin complex |
abstract |
The invention described herein relates to drug delivery complexes aimed at targeted therapies. The invention described herein relates to a method of treating folate-expressing cancer with a folate-tubulin complex. In addition, the invention described in this specification uses a folate-tubulin complex for a folic acid-expressing cancer in which a stable (SD) result is obtained after treatment with the folate-tubulin complex. Relates to a method of treatment. |
priorityDate |
2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |